|Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia|
A Ferrajoli, BN Lee, EJ Schlette, SM O'Brien, H Gao, S Wen, WG Wierda, ...
Blood, The Journal of the American Society of Hematology 111 (11), 5291-5297, 2008
|Phase II study of Lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non–adenoid cystic carcinoma …|
M Agulnik, EWE Cohen, RB Cohen, EX Chen, EE Vokes, SJ Hotte, ...
Journal of Clinical Oncology 25 (25), 3978-3984, 2007
|Epithelial–mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer|
A Giordano, H Gao, S Anfossi, E Cohen, M Mego, BN Lee, S Tin, ...
Molecular cancer therapeutics 11 (11), 2526-2534, 2012
|Expression of epithelial–mesenchymal transition‐inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy|
M Mego, SA Mani, BN Lee, C Li, KW Evans, EN Cohen, H Gao, ...
International journal of cancer 130 (4), 808-816, 2012
|Use of CAR-transduced natural killer cells in CD19-positive lymphoid tumors|
E Liu, D Marin, P Banerjee, HA Macapinlac, P Thompson, R Basar, ...
New England Journal of Medicine 382 (6), 545-553, 2020
|Detection of minimal residual disease in blood and bone marrow in early stage breast cancer|
S Krishnamurthy, M Cristofanilli, B Singh, J Reuben, H Gao, EN Cohen, ...
Cancer 116 (14), 3330-3337, 2010
|Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination|
M Giuliano, A Giordano, S Jackson, U De Giorgi, M Mego, EN Cohen, ...
Breast cancer research 16 (5), 1-9, 2014
|Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44+ CD24lo cancer stem …|
JM Reuben, BN Lee, H Gao, EN Cohen, M Mego, A Giordano, X Wang, ...
European journal of cancer 47 (10), 1527-1536, 2011
|Treatment with lenalidomide modulates T‐cell immunophenotype and cytokine production in patients with chronic lymphocytic leukemia|
BN Lee, H Gao, EN Cohen, X Badoux, WG Wierda, Z Estrov, SH Faderl, ...
Cancer 117 (17), 3999-4008, 2011
|Inflammation mediated metastasis: immune induced epithelial-to-mesenchymal transition in inflammatory breast cancer cells|
EN Cohen, H Gao, S Anfossi, M Mego, NG Reddy, B Debeb, A Giordano, ...
PloS one 10 (7), e0132710, 2015
|Synthetic tumor‐specific breakpoint peptide vaccine in patients with chronic myeloid leukemia and minimal residual disease: a phase 2 trial|
N Jain, JM Reuben, H Kantarjian, C Li, H Gao, BN Lee, EN Cohen, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2009
|High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast …|
S Anfossi, A Giordano, H Gao, EN Cohen, S Tin, Q Wu, RJ Garza, ...
PloS one 9 (1), e83113, 2014
|Prognostic value of EMT-circulating tumor cells in metastatic breast cancer patients undergoing high-dose chemotherapy with autologous hematopoietic stem cell transplantation|
M Mego, H Gao, BN Lee, EN Cohen, S Tin, A Giordano, Q Wu, P Liu, ...
Journal of Cancer 3, 369, 2012
|Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells|
BG Debeb, EN Cohen, K Boley, EM Freiter, L Li, FM Robertson, ...
Breast cancer research and treatment 134 (2), 495-510, 2012
|Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells|
BG Debeb, X Zhang, S Krishnamurthy, H Gao, E Cohen, L Li, ...
Molecular cancer 9 (1), 1-12, 2010
|The role of thalidomide and placebo for the treatment of cancer-related anorexia-cachexia symptoms: results of a double-blind placebo-controlled randomized study|
S Yennurajalingam, JS Willey, JL Palmer, J Allo, ED Fabbro, EN Cohen, ...
Journal of palliative medicine 15 (10), 1059-1064, 2012
|Immunotherapy of head and neck cancer: emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting|
JE Bauman, E Cohen, RL Ferris, DJ Adelstein, DM Brizel, JA Ridge, ...
Cancer 123 (7), 1259-1271, 2017
|Inflammatory markers and development of symptom burden in patients with multiple myeloma during autologous stem cell transplantation|
XS Wang, Q Shi, ND Shah, CJ Heijnen, EN Cohen, JM Reuben, ...
Clinical Cancer Research 20 (5), 1366-1374, 2014
|Modification of a hydrophobic layer by a point mutation in syntaxin 1A regulates the rate of synaptic vesicle fusion|
RD Lagow, H Bao, EN Cohen, RW Daniels, A Zuzek, WH Williams, ...
PLoS Biol 5 (4), e72, 2007
|Circulating tumor cells (CTC) are associated with defects in adaptive immunity in patients with inflammatory breast cancer|
M Mego, H Gao, EN Cohen, S Anfossi, A Giordano, T Sanda, TM Fouad, ...
Journal of Cancer 7 (9), 1095, 2016